Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Factors that modify the risk of intraoperative seizures triggered by electrical stimulation during supratentorial functional mapping.

Dineen J, Maus DC, Muzyka I, See RB, Cahill DP, Carter BS, Curry WT, Jones PS, Nahed BV, Peterfreund RA, Simon MV.

Clin Neurophysiol. 2019 Jun;130(6):1058-1065. doi: 10.1016/j.clinph.2019.03.006. Epub 2019 Mar 23.

PMID:
30930194
2.

Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping.

Choi BD, Lee DK, Yang JC, Ayinon CM, Lee CK, Maus D, Carter BS, Barker FG, Jones PS, Nahed BV, Cahill DP, See RB, Simon MV, Curry WT.

J Neurosurg. 2019 Mar 29:1-7. doi: 10.3171/2018.12.JNS182700. [Epub ahead of print]

PMID:
30925466
3.

Navigating the Landscape of Tumor Extracellular Vesicle Heterogeneity.

Roy S, Lin HY, Chou CY, Huang CH, Small J, Sadik N, Ayinon CM, Lansbury E, Cruz L, Yekula A, Jones PS, Balaj L, Carter BS.

Int J Mol Sci. 2019 Mar 18;20(6). pii: E1349. doi: 10.3390/ijms20061349. Review.

4.

In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier.

Bevan-Jones WR, Cope TE, Jones PS, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FI, O'Brien JT, Rowe JB.

Ann Clin Transl Neurol. 2019 Jan 2;6(2):373-378. doi: 10.1002/acn3.683. eCollection 2019 Feb.

5.

Further evidence for a non-cortical origin of mirror movements after stroke.

Calautti C, Jones PS, Naccarato M, Sharma N, Carpenter TA, Warburton EA, Baron JC.

Brain. 2019 Jan 1;142(1):e1. doi: 10.1093/brain/awy308. No abstract available.

PMID:
30596902
6.

A framework for the development of effective anti-metastatic agents.

Anderson RL, Balasas T, Callaghan J, Coombes RC, Evans J, Hall JA, Kinrade S, Jones D, Jones PS, Jones R, Marshall JF, Panico MB, Shaw JA, Steeg PS, Sullivan M, Tong W, Westwell AD, Ritchie JWA; Cancer Research UK and Cancer Therapeutics CRC Australia Metastasis Working Group.

Nat Rev Clin Oncol. 2019 Mar;16(3):185-204. doi: 10.1038/s41571-018-0134-8. Review.

PMID:
30514977
7.

A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

Fujio S, Juratli TA, Arita K, Hirano H, Nagano Y, Takajo T, Yoshimoto K, Bihun IV, Kaplan AB, Nayyar N, Fink AL, Bertalan MS, Tummala SS, Curry WT Jr, Jones PS, Martinez-Lage M, Cahill DP, Barker FG 2nd, Brastianos PK.

Neurosurgery. 2018 Nov 27. doi: 10.1093/neuros/nyy569. [Epub ahead of print]

PMID:
30481321
8.

Commentary: Predicting Inpatient Length of Stay After Brain Tumor Surgery: Developing Machine Learning Ensembles to Improve Predictive Performance.

Udelsman BV, Jones PS, Bababekov YJ, Carter BS, Chang DC.

Neurosurgery. 2018 Oct 17. doi: 10.1093/neuros/nyy453. [Epub ahead of print] No abstract available.

PMID:
30335162
9.

Isocitrate Dehydrogenase Mutations in Low-Grade Gliomas Correlate With Prolonged Overall Survival in Older Patients.

Jones PS, Carroll KT, Koch M, DiCesare JAT, Reitz K, Frosch M, Barker FG 2nd, Cahill DP, Curry WT Jr.

Neurosurgery. 2019 Feb 1;84(2):519-528. doi: 10.1093/neuros/nyy149.

PMID:
29846690
10.

[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy.

Passamonti L, Rodríguez PV, Hong YT, Allinson KSJ, Bevan-Jones WR, Williamson D, Jones PS, Arnold R, Borchert RJ, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB.

Neurology. 2018 May 29;90(22):e1989-e1996. doi: 10.1212/WNL.0000000000005610. Epub 2018 Apr 27.

11.

An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE.

Josephs DH, Nakamura M, Bax HJ, Dodev TS, Muirhead G, Saul L, Karagiannis P, Ilieva KM, Crescioli S, Gazinska P, Woodman N, Lombardelli C, Kareemaghay S, Selkirk C, Lentfer H, Barton C, Canevari S, Figini M, Downes N, Dombrowicz D, Corrigan CJ, Nestle FO, Jones PS, Gould HJ, Blower PJ, Tsoka S, Spicer JF, Karagiannis SN.

Allergy. 2018 Dec;73(12):2328-2341. doi: 10.1111/all.13455. Epub 2018 Oct 8.

12.

Extracellular vesicles: the growth as diagnostics and therapeutics; a survey.

Roy S, Hochberg FH, Jones PS.

J Extracell Vesicles. 2018 Feb 26;7(1):1438720. doi: 10.1080/20013078.2018.1438720. eCollection 2018. Review.

13.

White matter change with apathy and impulsivity in frontotemporal lobar degeneration syndromes.

Lansdall CJ, Coyle-Gilchrist ITS, Jones PS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Dick KM, Robbins TW, Rowe JB.

Neurology. 2018 Mar 20;90(12):e1066-e1076. doi: 10.1212/WNL.0000000000005175. Epub 2018 Feb 16.

14.

Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.

Cope TE, Rittman T, Borchert RJ, Jones PS, Vatansever D, Allinson K, Passamonti L, Vazquez Rodriguez P, Bevan-Jones WR, O'Brien JT, Rowe JB.

Brain. 2018 Feb 1;141(2):550-567. doi: 10.1093/brain/awx347.

15.

Evidence for causal top-down frontal contributions to predictive processes in speech perception.

Cope TE, Sohoglu E, Sedley W, Patterson K, Jones PS, Wiggins J, Dawson C, Grube M, Carlyon RP, Griffiths TD, Davis MH, Rowe JB.

Nat Commun. 2017 Dec 18;8(1):2154. doi: 10.1038/s41467-017-01958-7.

16.

An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease.

Underwood BR, Green-Thompson ZW, Pugh PJ, Lazic SE, Mason SL, Griffin J, Jones PS, Rowe JB, Rubinsztein DC, Barker RA.

J Neurol. 2017 Dec;264(12):2457-2463. doi: 10.1007/s00415-017-8647-0. Epub 2017 Oct 26.

17.

[18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia.

Bevan-Jones WR, Cope TE, Jones PS, Passamonti L, Hong YT, Fryer TD, Arnold R, Allinson KSJ, Coles JP, Aigbirhio FI, Patterson K, O'Brien JT, Rowe JB.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1032-1037. doi: 10.1136/jnnp-2017-316402. Epub 2017 Sep 14.

18.

Correlates of Perceived Social Support in Chinese Adult Child Caregivers of Parent Stroke Survivors.

Pan Y, Jones PS.

J Nurs Res. 2017 Oct;25(5):383-391. doi: 10.1097/JNR.0000000000000173.

PMID:
28877126
19.

Artificial grammar learning in vascular and progressive non-fluent aphasias.

Cope TE, Wilson B, Robson H, Drinkall R, Dean L, Grube M, Jones PS, Patterson K, Griffiths TD, Rowe JB, Petkov CI.

Neuropsychologia. 2017 Sep;104:201-213. doi: 10.1016/j.neuropsychologia.2017.08.022. Epub 2017 Aug 24.

20.

The Relationship Between Mutuality and Health-Related Quality of Life in Adult Child Caregivers in China.

Pan Y, Jones PS, Pothier P.

J Fam Nurs. 2017 Aug;23(3):366-391. doi: 10.1177/1074840717718540. Epub 2017 Jul 24.

PMID:
28795855
21.

Apathy and impulsivity in frontotemporal lobar degeneration syndromes.

Lansdall CJ, Coyle-Gilchrist ITS, Jones PS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Dick KM, Robbins TW, Rowe JB.

Brain. 2017 Jun 1;140(6):1792-1807. doi: 10.1093/brain/awx101.

22.

In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's Disease.

Aitken L, Baillie G, Pannifer A, Morrison A, Jones PS, Smith TK, McElroy SP, Gunn-Moore FJ.

SLAS Discov. 2017 Jul;22(6):676-685. doi: 10.1177/2472555217697964. Epub 2017 Mar 17.

PMID:
28314118
23.

Disrupted iron regulation in the brain and periphery in cocaine addiction.

Ersche KD, Acosta-Cabronero J, Jones PS, Ziauddeen H, van Swelm RP, Laarakkers CM, Raha-Chowdhury R, Williams GB.

Transl Psychiatry. 2017 Feb 21;7(2):e1040. doi: 10.1038/tp.2016.271.

24.

18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.

Passamonti L, Vázquez Rodríguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, Sami S, Cope TE, Bevan-Jones WR, Jones PS, Arnold R, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB.

Brain. 2017 Mar 1;140(3):781-791. doi: 10.1093/brain/aww340.

25.

Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling.

Josephs DH, Bax HJ, Dodev T, Georgouli M, Nakamura M, Pellizzari G, Saul L, Karagiannis P, Cheung A, Herraiz C, Ilieva KM, Correa I, Fittall M, Crescioli S, Gazinska P, Woodman N, Mele S, Chiaruttini G, Gilbert AE, Koers A, Bracher M, Selkirk C, Lentfer H, Barton C, Lever E, Muirhead G, Tsoka S, Canevari S, Figini M, Montes A, Downes N, Dombrowicz D, Corrigan CJ, Beavil AJ, Nestle FO, Jones PS, Gould HJ, Sanz-Moreno V, Blower PJ, Spicer JF, Karagiannis SN.

Cancer Res. 2017 Mar 1;77(5):1127-1141. doi: 10.1158/0008-5472.CAN-16-1829. Epub 2017 Jan 17.

26.

The SULSA Assay Development Fund: accelerating translation of new biology from academia to pharma.

McElroy SP, Jones PS, Barrault DV.

Drug Discov Today. 2017 Feb;22(2):199-203. doi: 10.1016/j.drudis.2016.09.028. Epub 2016 Oct 5.

27.

The Relationship Between Mutuality, Filial Piety, and Depression in Family Caregivers in China.

Pan Y, Jones PS, Winslow BW.

J Transcult Nurs. 2017 Sep;28(5):455-463. doi: 10.1177/1043659616657877. Epub 2016 Jul 13.

PMID:
27413164
28.

Atomoxetine restores the response inhibition network in Parkinson's disease.

Rae CL, Nombela C, Rodríguez PV, Ye Z, Hughes LE, Jones PS, Ham T, Rittman T, Coyle-Gilchrist I, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB.

Brain. 2016 Aug;139(Pt 8):2235-48. doi: 10.1093/brain/aww138. Epub 2016 Jun 24.

29.

Carrots and sticks fail to change behavior in cocaine addiction.

Ersche KD, Gillan CM, Jones PS, Williams GB, Ward LH, Luijten M, de Wit S, Sahakian BJ, Bullmore ET, Robbins TW.

Science. 2016 Jun 17;352(6292):1468-71. doi: 10.1126/science.aaf3700.

30.

Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease.

Breen DP, Nombela C, Vuono R, Jones PS, Fisher K, Burn DJ, Brooks DJ, Reddy AB, Rowe JB, Barker RA.

Mov Disord. 2016 Jul;31(7):1062-6. doi: 10.1002/mds.26592. Epub 2016 Mar 12.

31.

Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma.

Curry WT Jr, Gorrepati R, Piesche M, Sasada T, Agarwalla P, Jones PS, Gerstner ER, Golby AJ, Batchelor TT, Wen PY, Mihm MC, Dranoff G.

Clin Cancer Res. 2016 Jun 15;22(12):2885-96. doi: 10.1158/1078-0432.CCR-15-2163. Epub 2016 Feb 12.

32.

Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.

Ye Z, Rae CL, Nombela C, Ham T, Rittman T, Jones PS, Rodríguez PV, Coyle-Gilchrist I, Regenthal R, Altena E, Housden CR, Maxwell H, Sahakian BJ, Barker RA, Robbins TW, Rowe JB.

Hum Brain Mapp. 2016 Mar;37(3):1026-37. doi: 10.1002/hbm.23087. Epub 2016 Jan 12.

33.

Does stroke location predict walk speed response to gait rehabilitation?

Jones PS, Pomeroy VM, Wang J, Schlaug G, Tulasi Marrapu S, Geva S, Rowe PJ, Chandler E, Kerr A, Baron JC; SWIFT-Cast investigators.

Hum Brain Mapp. 2016 Feb;37(2):689-703. doi: 10.1002/hbm.23059. Epub 2015 Nov 19.

34.

The ELF Honest Data Broker: informatics enabling public-private collaboration in a precompetitive arena.

Paillard G, Cochrane P, Jones PS, van Hoorn WP, Caracoti A, van Vlijmen H, Pannifer AD.

Drug Discov Today. 2016 Jan;21(1):97-102. doi: 10.1016/j.drudis.2015.11.005. Epub 2015 Nov 19. Review.

35.

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka DJ, Sullivan RJ, Frederick DT, Abedalthagafi M, Jones PS, Dunn IF, Nahed BV, Romero JM, Louis DN, Getz G, Cahill DP, Santagata S, Curry WT Jr, Barker FG 2nd.

J Natl Cancer Inst. 2015 Oct 23;108(2). pii: djv310. doi: 10.1093/jnci/djv310. Print 2016 Feb.

36.

In the face of threat: neural and endocrine correlates of impaired facial emotion recognition in cocaine dependence.

Ersche KD, Hagan CC, Smith DG, Jones PS, Calder AJ, Williams GB.

Transl Psychiatry. 2015 May 26;5:e570. doi: 10.1038/tp.2015.58.

37.

Is CT-Based Perfusion and Collateral Imaging Sensitive to Time Since Stroke Onset?

Agarwal S, Matys T, Marrapu ST, Scoffings DJ, Mitchell J, Jones PS, Baron JC, Warburton EA.

Front Neurol. 2015 Apr 9;6:70. doi: 10.3389/fneur.2015.00070. eCollection 2015.

38.

Biased visualization of hypoperfused tissue by computed tomography due to short imaging duration: improved classification by image down-sampling and vascular models.

Mikkelsen IK, Jones PS, Ribe LR, Alawneh J, Puig J, Bekke SL, Tietze A, Gillard JH, Warburton EA, Pedraza S, Baron JC, Østergaard L, Mouridsen K.

Eur Radiol. 2015 Jul;25(7):2080-8. doi: 10.1007/s00330-015-3602-x. Epub 2015 Apr 17.

PMID:
25894005
39.

Use of computer decision support in an antimicrobial stewardship program (ASP).

Evans RS, Olson JA, Stenehjem E, Buckel WR, Thorell EA, Howe S, Wu X, Jones PS, Lloyd JF.

Appl Clin Inform. 2015 Mar 3;6(1):120-35. doi: 10.4338/ACI-2014-11-RA-0102. eCollection 2015.

40.

Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.

Jones PS, Cahill DP, Brastianos PK, Flaherty KT, Curry WT.

Neurosurg Focus. 2015 Mar;38(3):E5. doi: 10.3171/2014.12.FOCUS14698.

PMID:
25727227
41.

The Joint European Compound Library: boosting precompetitive research.

Besnard J, Jones PS, Hopkins AL, Pannifer AD.

Drug Discov Today. 2015 Feb;20(2):181-6. doi: 10.1016/j.drudis.2014.08.014. Epub 2014 Sep 6.

42.

Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.

Jones PS, Aghi MK, Muzikansky A, Shih HA, Barker FG 2nd, Curry WT Jr.

J Clin Neurosci. 2014 Sep;21(9):1490-6. doi: 10.1016/j.jocn.2014.02.008. Epub 2014 May 19.

PMID:
24852903
43.

Outcomes and patterns of care in adult skull base chondrosarcomas from the SEER database.

Jones PS, Aghi MK, Muzikansky A, Shih HA, Barker FG 2nd, Curry WT Jr.

J Clin Neurosci. 2014 Sep;21(9):1497-502. doi: 10.1016/j.jocn.2014.02.005. Epub 2014 Apr 30.

PMID:
24792724
44.

A wavelet method for modeling and despiking motion artifacts from resting-state fMRI time series.

Patel AX, Kundu P, Rubinov M, Jones PS, Vértes PE, Ersche KD, Suckling J, Bullmore ET.

Neuroimage. 2014 Jul 15;95:287-304. doi: 10.1016/j.neuroimage.2014.03.012. Epub 2014 Mar 21.

45.

Diffusion and perfusion correlates of the 18F-MISO PET lesion in acute stroke: pilot study.

Alawneh JA, Moustafa RR, Marrapu ST, Jensen-Kondering U, Morris RS, Jones PS, Aigbirhio FI, Fryer TD, Carpenter TA, Warburton EA, Baron JC.

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):736-44. doi: 10.1007/s00259-013-2581-x. Epub 2013 Oct 15.

PMID:
24126468
46.

Aberrant disgust responses and immune reactivity in cocaine-dependent men.

Ersche KD, Hagan CC, Smith DG, Abbott S, Jones PS, Apergis-Schoute AM, Döffinger R.

Biol Psychiatry. 2014 Jan 15;75(2):140-7. doi: 10.1016/j.biopsych.2013.08.004. Epub 2013 Oct 3.

47.

Overlapping decline in orbitofrontal gray matter volume related to cocaine use and body mass index.

Smith DG, Jones PS, Williams GB, Bullmore ET, Robbins TW, Ersche KD.

Addict Biol. 2015 Jan;20(1):194-6. doi: 10.1111/adb.12081. Epub 2013 Aug 8.

PMID:
23927455
48.

Is neural activation within the rescued penumbra impeded by selective neuronal loss?

Carrera E, Jones PS, Morris RS, Alawneh J, Hong YT, Aigbirhio FI, Fryer TD, Carpenter TA, Warburton EA, Baron JC.

Brain. 2013 Jun;136(Pt 6):1816-29. doi: 10.1093/brain/awt112. Epub 2013 May 16.

PMID:
23682070
49.

Cognitive control dysfunction and abnormal frontal cortex activation in stimulant drug users and their biological siblings.

Smith DG, Jones PS, Bullmore ET, Robbins TW, Ersche KD.

Transl Psychiatry. 2013 May 14;3:e257. doi: 10.1038/tp.2013.32.

50.

Assessing user preferences for e-readers and tablets.

Le Ber JM, Lombardo NT, Honisett A, Jones PS, Weber A.

Med Ref Serv Q. 2013;32(1):1-11. doi: 10.1080/02763869.2013.749101.

PMID:
23394416

Supplemental Content

Loading ...
Support Center